Guy's and St. Thomas' NHS Foundation Trust

London, England SE1 9RT

2 studies enrolling now · 8 studies all time

What they study most

Advanced Melanoma, Advanced Solid Tumor With Evidence of Germline or Somatic BRCA, Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP), Fallopian Tube Cancer, Mast Cell Leukemia, Metastatic Castration Resistant Prostate Cancer, Myelofibrosis, Ovarian Cancer, Peritoneal Cancer

Studies at this site

• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. — Recruiting now
• Study of Bitopertin in Participants With EPP or XLP (APOLLO) — Running, not enrolling
• HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP — Enrolling by invitation
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
• A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) — Completed
• A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC — Stopped early
• Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM — Completed